Pfizer-BioNTech’s COVID-19 vaccine for kids under five has been approved by Health Canada, making it the second vaccine option for children in this age group.
Health Canada has approved a three-dose primary series of three micrograms each of Pfizer-BioNTech’s vaccine for children aged six months to four years old.
That differs from Moderna’s vaccine for this age group, a two-dose series and a higher amount of vaccine per dose which was approved in July.
The government recently approved a newer version of Moderna’s vaccine that targets the Omicron variant of COVID-19, but its use has not yet been approved for the youngest cohort.